Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.

Item
http://www.wikidata.org/entity/Q46899628
A comparison of different antibiotic regimens for the treatment of infective endocarditisClinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patientsThrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment.Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort studyPredictors of mortality in Staphylococcus aureus BacteremiaPredictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus BacteremiaComparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective StudyAdjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia.Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia?Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.Methicillin-sensitive Staphylococcus aureus bacteremia in aged patients: the importance of formal infectious specialist consultation.
P2860

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.

Item
http://www.wikidata.org/entity/Q46899628
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Levofloxacin does not decrease ...... linical trial of 381 patients.
@en
Levofloxacin does not decrease ...... linical trial of 381 patients.
@nl
type
label
Levofloxacin does not decrease ...... linical trial of 381 patients.
@en
Levofloxacin does not decrease ...... linical trial of 381 patients.
@nl
prefLabel
Levofloxacin does not decrease ...... linical trial of 381 patients.
@en
Levofloxacin does not decrease ...... linical trial of 381 patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Levofloxacin does not decrease ...... linical trial of 381 patients.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2796.2005.01598.X
P407
P433
P478
P577
P5875
P698